New drugs in gynecologic cancer Journal Article
| Authors: | Daud, A.; Munster, P.; Spriggs, D. R. |
| Article Title: | New drugs in gynecologic cancer |
| Abstract: | The implementation of new drug treatments has improved the prognosis for advanced cancers of the cervix, uterus, and ovary. Platinum analogs are the most effective drugs in the treatment of ovarian cancer. Other drugs, such as oxaliplatin, have been proposed as a rational treatment of platinum refractory ovarian cancer. Epothilones are also being studied in clinical trials, as are histone deacetylase inhibitors. Several promising agents may soon receive Food and Drug Administration approval. |
| Keywords: | review; cisplatin; antineoplastic agents; paclitaxel; antineoplastic agent; bortezomib; boronic acids; pyrazines; protein tyrosine kinase; monoclonal antibody; genital neoplasms, female; antibodies, monoclonal; antiinfective agent; drug antagonism; anti-bacterial agents; gefitinib; drug derivative; hydroxamic acids; protein-tyrosine kinases; platinum complex; trastuzumab; quinazolines; organoplatinum compounds; boronic acid derivative; pyrazine derivative; quinazoline derivative; hydroxamic acid; female genital tract tumor; lactams, macrocyclic; macrocyclic lactam; pyroxamide; humans; human; female; aminopyridines; aminopyridine derivative; amminedichloro(2 methylpyridine)platinum(ii); amminedichloro(2-methylpyridine)platinum(ii); bbr 3464 |
| Journal Title: | Current Treatment Options in Oncology |
| Volume: | 2 |
| Issue: | 2 |
| ISSN: | 1527-2729 |
| Publisher: | Springer |
| Date Published: | 2001-04-01 |
| Start Page: | 119 |
| End Page: | 128 |
| Language: | English |
| PUBMED: | 12057130 |
| PROVIDER: | scopus |
| DOI: | 10.1007/s11864-001-0054-0 |
| DOI/URL: | |
| Notes: | Export Date: 21 May 2015 -- Source: Scopus |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work